| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
STRR Stock Overview
Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally.
Star Equity Holdings Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.93 |
| 52 Week High | US$4.67 |
| 52 Week Low | US$0.72 |
| Beta | 0.42 |
| 1 Month Change | -6.00% |
| 3 Month Change | -17.69% |
| 1 Year Change | -70.00% |
| 3 Year Change | -84.80% |
| 5 Year Change | -97.79% |
| Change since IPO | -99.21% |
Recent News & Updates
Shareholder Returns
| STRR | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -1.1% | 4.1% | 1.6% |
| 1Y | -70.0% | 5.0% | -20.8% |
Return vs Industry: STRR underperformed the US Healthcare industry which returned 3.8% over the past year.
Return vs Market: STRR underperformed the US Market which returned -20.4% over the past year.
Price Volatility
| STRR volatility | |
|---|---|
| STRR Average Weekly Movement | 12.1% |
| Healthcare Industry Average Movement | 9.5% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: STRR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: STRR's weekly volatility (12%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 458 | Rick Coleman | https://www.starequity.com |
Star Equity Holdings, Inc. provides healthcare solutions in the United States and internationally. It operates through four segments: Diagnostic Services, Diagnostic Imaging, Construction, and Investments. It offers imaging services primarily to cardiologists, internal medicine physicians, and family practice doctors; and imaging systems, including nuclear cardiac and general purpose nuclear imaging systems to physician offices and hospitals.
Star Equity Holdings Fundamentals Summary
| STRR fundamental statistics | |
|---|---|
| Market Cap | US$14.03m |
| Earnings (TTM) | -US$13.95m |
| Revenue (TTM) | US$109.25m |
0.1x
P/S Ratio-1.0x
P/E RatioIs STRR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STRR income statement (TTM) | |
|---|---|
| Revenue | US$109.25m |
| Cost of Revenue | US$92.43m |
| Gross Profit | US$16.83m |
| Other Expenses | US$30.78m |
| Earnings | -US$13.95m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.92 |
| Gross Margin | 15.40% |
| Net Profit Margin | -12.77% |
| Debt/Equity Ratio | 30.0% |
How did STRR perform over the long term?
See historical performance and comparisonValuation
Is STRR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
PEG Ratio
Key Valuation Metric
Which metric is best to use when looking at relative valuation for STRR?
Other financial metrics that can be useful for relative valuation.
| What is STRR's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$14.03m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.3x |
| Enterprise Value/EBITDA | -8.4x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does STRR's PS Ratio compare to its peers?
| STRR PS Ratio vs Peers |
|---|
| Company | PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.4x | ||
GMVD G Medical Innovations Holdings | 2.9x | n/a | US$14.9m |
AMS American Shared Hospital Services | 0.8x | n/a | US$13.7m |
CLRD Clearday | 1.5x | n/a | US$18.1m |
IDXG Interpace Biosciences | 0.3x | 15.2% | US$13.2m |
STRR Star Equity Holdings | 0.1x | 7.7% | US$14.0m |
Price-To-Sales vs Peers: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1.4x).
Price to Earnings Ratio vs Industry
How does STRR's PE Ratio compare vs other companies in the US Healthcare Industry?
Price-To-Sales vs Industry: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the US Healthcare industry average (1.4x)
Price to Sales Ratio vs Fair Ratio
What is STRR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | 0.4x |
Price-To-Sales vs Fair Ratio: STRR is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.4x).
Share Price vs Fair Value
What is the Fair Price of STRR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate STRR's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate STRR's fair value for valuation analysis.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate STRR's PEG Ratio to determine if it is good value.
Discover undervalued companies
Future Growth
How is Star Equity Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
79.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: STRR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: STRR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: STRR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: STRR's revenue (7.7% per year) is forecast to grow slower than the US market (8.3% per year).
High Growth Revenue: STRR's revenue (7.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if STRR's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Past Performance
How has Star Equity Holdings performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
19.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: STRR is currently unprofitable.
Growing Profit Margin: STRR is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: STRR is unprofitable, but has reduced losses over the past 5 years at a rate of 19% per year.
Accelerating Growth: Unable to compare STRR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: STRR is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.8%).
Return on Equity
High ROE: STRR has a negative Return on Equity (-27.1%), as it is currently unprofitable.
Discover strong past performing companies
Financial Health
How is Star Equity Holdings's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: STRR's short term assets ($44.8M) exceed its short term liabilities ($30.7M).
Long Term Liabilities: STRR's short term assets ($44.8M) exceed its long term liabilities ($6.0M).
Debt to Equity History and Analysis
Debt Level: STRR has more cash than its total debt.
Reducing Debt: STRR's debt to equity ratio has reduced from 31.4% to 30% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: STRR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: STRR has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 60.2% each year
Discover healthy companies
Dividend
What is Star Equity Holdings's current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate STRR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate STRR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if STRR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if STRR's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: STRR is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as STRR has not reported any payouts.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
3.4yrs
Average management tenure
CEO
Rick Coleman (65 yo)
0.25
Tenure
Mr. Richard Kenneth Coleman, Jr., also known as Rick, has been Chief Executive Officer of Star Equity Holdings, Inc. from March 2022 and serves as Director since May 31, 2022. He was Chief Operating Office...
Leadership Team
Experienced Management: STRR's management team is considered experienced (3.4 years average tenure).
Board Members
Experienced Board: STRR's board of directors are considered experienced (8.4 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: STRR insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 200.5%.
Top Shareholders
Company Information
Star Equity Holdings, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Star Equity Holdings, Inc.
- Ticker: STRR
- Exchange: NasdaqGM
- Founded: 1985
- Industry: Health Care Services
- Sector: Healthcare
- Implied Market Cap: US$14.028m
- Shares outstanding: 15.08m
- Website: https://www.starequity.com
Number of Employees
Location
- Star Equity Holdings, Inc.
- 53 Forest Avenue
- Suite 101
- Old Greenwich
- Connecticut
- 6870
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/06/29 00:00 |
| End of Day Share Price | 2022/06/29 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.